I (2010-2017)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2017

+Studies in 2000-2009 List
*Studies in Pre-2000 List

IBS/IBD + (See Also BOWEL DISORDERS)
IMMUNE SYSTEM*+
IMMUNE THROMBOCYTOPENIA
INCONTINENCE (See BLADDER)
INDICATIONS AND CLINICAL USES*+
INFANTS (0 to 2 years) (See Also GERMINAL MATRIX HEMORRHAGE)
INFLAMMATION*
INFLUENZA (See FLU/INFLUENZA)
INJURIES (See WOUNDS AND INJURIES)
INTERACTIONS WITH OTHER DRUGS*+
INTRAVENTRICULAR HEMORRHAGE (Bleeding Into Fluid-filled Areas [Ventricles] of Brain)
ISAACS’ SYNDROME/ACQUIRED NEUROMYOTONIA +
IQ/MEMORY/COGNITIVE EFFECTS*+
ITCH (See PRURITIS)


IBS/IBD
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice (full–2010) http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00132/full
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?tool=pubmed
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease (full–2011) http://www.nature.com/mi/journal/v4/n5/full/mi201118a.html
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01742.x/full
Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel Syndrome (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202649/
Cannabis use amongst patients with inflammatory bowel disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21795981
Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20505532
Role of cannabinoid receptors and RAGE in inflammatory bowel disease (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21472688/abstract/Role_of_cannabinoid_receptors_and_RAGE_in_inflammatory_bowel_disease_
top
Irritable bowel syndrome: a dysfunction of the endocannabinoid system? (full–2012) http://www.gastrojournal.org/article/S0016-5085%2811%2901710-0/fulltext
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility (full–2012) http://content.karger.com/produktedb/produkte.asp?DOI=000339072&typ=pdf
Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362100/
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome (full–2012) http://ajpgi.physiology.org/content/302/10/G1075
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775711/
Gut microbiota and the development of obesity (full–2012) http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000500007&lng=en&nrm=iso&tlng=en
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22917662?dopt=Abstract
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22815234
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22917662
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22815234
Agents that act luminally to treat diarrhoea and constipation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22945441
Cannabis Finds Its Way into Treatment of Crohn’s Disease (full–2013) http://www.karger.com/Article/Pdf/356512
Role of endogenous cannabinoid system in the gut (full-2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
Irritable Bowel Syndrome and Migraine: Bystanders or Partners? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714407/
Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874007/
Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602676/
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis (full–2013) http://www.nature.com/labinvest/journal/v93/n3/full/labinvest2012177a.html
Marijuana use patterns among patients with inflammatory bowel disease (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126607/
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study (full–2013) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085073
Industrial hemp decreases intestinal motility stronger than indian hemp in mice (link to PDF–2013) http://www.europeanreview.org/article/3266
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23415610
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454360
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system (abst–2013) http://www.sciencedirect.com/science/article/pii/S0161589013000382
Cannabidiol in inflammatory bowel diseases: a brief overview (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22815234
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24238999
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24275607
top
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation (abst–2013) http://onlinelibrary.wiley.com/doi/10.1111/jgh.12346/abstract
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
Genetic polymorphism in pathogenesis of irritable bowel syndrome (full–2014) http://www.wjgnet.com/1007-9327/full/v20/i47/17693.htm
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12907/full
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183544/
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12272/full
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not “higher” (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12329/full
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243976/
Medical Marijuana for Digestive Disorders: High Time to Prescribe? (full–2014) http://www.nature.com/ajg/journal/v110/n2/full/ajg2014245a.html
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615720/
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon Npalmitoylethanolamine levels and counteracts murine colitis (full–2014) http://www.fasebj.org/content/29/2/650.long
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24444427
Switching cannabinoid response from CB2 agonists to FAAH inhibitors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508127
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24813296
The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuro-neuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24911079
Cannabis for inflammatory bowel disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24969296
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology (abst-2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (full–2014) http://tinyurl.com/hss39v9
top
Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25499880
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25599774
Pharmacogenetics in irritable bowel syndrome (full–2015) http://informahealthcare.com/doi/pdf/10.1517/17425255.2015.1048223
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26075589
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25505251
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (abst–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13069/abstract
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26387676
Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26254701
Cannabis – therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408170
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population-based analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26422462
Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes (full-2016) http://jpet.aspetjournals.org/content/early/2016/03/21/jpet.116.232553.long Endocannabinoids in the Gut (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940133/
The CB2 receptor and its role as a regulator of inflammation (full–2016) http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK (full–2016) http://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse (full-2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047908/
Therapeutic Use of Cannabis in Inflammatory Bowel Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments (full–2016) http://www.ncbi.nlm.nih.gov/pubmed/27431236 Getting into the weed: the role of the endocannabinoid system in the brain-gut axis (link to full via ELSEVIER–2016) http://www.ncbi.nlm.nih.gov/pubmed/27133395
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26809974
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26817719
The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561826
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27579692
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23–IL-17 signalling in macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302499
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26809974
Cannabinoids and GI Disorders: Endogenous and Exogenous (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27699625 Role of cannabis in digestive disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27792038
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26561079
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
Role of cannabis in digestive disorders (abst–2017) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10 &index=3


IMMUNE SYSTEM
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity (full-2010) http://www.nature.com/aps/journal/v31/n12/full/aps2010155a.html
Do cannabinoids have a therapeutic role in transplantation? (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923447/?tool=pubmed
Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109320/
Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties (full-2010) http://onlinelibrary.wiley.com/doi/10.1002/eji.201040667/full
top
Cannabinoids and Viral Infections (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903762/?tool=pmcentrez
Cannabinoids and the immune system: an overview (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20153077
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069975/?tool=pmcentrez
New blood brothers: the GPR55 and CB2 partnership (full–2011) http://www.nature.com/cr/journal/vaop/ncurrent/full/cr201177a.html
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137183/?tool=pubmed
Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis (full–2011) http://msj.sagepub.com/content/17/3/259.long
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
Cannabinoid Receptor 2 Is Critical for the Homing and Retention of Marginal Zone B Lineage Cells and for Efficient T-Independent Immune Responses (full–2011) http://www.jimmunol.org/content/187/11/5720.full.pdf+html
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206470/
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171627/
Modulation of the novel cannabinoid receptor – GPR55 – during rat fetoplacental development (full–2011) http://www.placentajournal.org/article/S0143-4004%2811%2900110-X/fulltext
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF–2011) http://www.tswj.com/2011/230786/abs/
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21626285
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21310228
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1
neuropathogenesis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21850403
Cannabis use and Cognitive Function: Eight Year Trajectory in a Young Adult Cohort (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21749524
Cannabinoids and sepsis (abst–2011) http://www.trendsanaesthesiacriticalcare.com/article/S2210-8440%2811%2900049-9/fulltext
Dynamic changes to the endocannabinoid system in models of chronic pain (full-2012)
http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Upregulation of Serum IgE Levels in Immunized Mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419805/
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342927/
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington’s Disease (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753072/
top
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3312.long
Endocannabinoid modulation of jejunal afferent responses to LPS (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2012.01961.x/full
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476512/
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22367605
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis (abst–2012)  http://www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/116.7?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22652530
Immunity and early pregnancy events: are endocannabinoids the missing link? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23177537
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120 (full–2013) http://www.jleukbio.org/content/92/5/1093.full
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice (full–2013) http://www.hindawi.com/journals/mi/2013/741303/
Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-Tetrahydrocannabinol in vivo: Regulation of CCAAT/enhancer binding protein alpha by microRNA-690 (full–2013) http://www.jbc.org/content/early/2013/11/07/jbc.M113.503037.long
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immuno-suppressive properties (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080022
Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens (full–2013)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067587
2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release anti-microbial effectors against E. coli, S. aureus, HSV-1, and RSV (full–2013) http://www.jleukbio.org/content/93/2/267.long
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877544/
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641032/
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Multiple sclerosis and the blood-central nervous system barrier (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663904/
top
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full–2013) http://www.sciencedirect.com/science/article/pii/S0969996113001939
Cannabinoid (CB)1 receptors are critical for the innate immune response to TLR4 stimulation (full–2013) http://ajpregu.physiology.org/content/305/3/R224
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (full–2013) http://www.biochemsoctrans.org/content/41/6/1577
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864984/
Cannabinoid receptor modulation of the endothelial cell inflammatory response (abst–2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/112.29?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Cytokine release in sepsis (full–2013) http://file.scirp.org/Html/36257.html
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634783/
Targeting the Endocannabinoid System to Treat Sepsis (review–2013) http://www.signavitae.com/2013/05/targeting-the-endocannabinoid-system-to-treat-sepsis/
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic child-hood immune thrombocytopenia in Egypt (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23406660
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst–2013) http://www.eurekaselect.com/106175/article
Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome (abst–2013) http://www.medical-hypotheses.com/article/S0306-9877%2814%2900117-0/abstract
G-protein coupled receptor 18 (GPR18) in channel catfish: expression analysis and efficacy as immunostimulant against Aeromonas hydrophila infection (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23891864
Cannabinoids decrease the th17 inflammatory autoimmune phenotype (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23892791
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists (abst–2013) http://pubs.acs.org/doi/abs/10.1021/jm4005626
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080545/
Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974854/
Polyunsaturated Fatty Acid-Derived Lipid Mediators and T Cell Function (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/24611066
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full–2014) http://www.hindawi.com/journals/mi/2014/978678/
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996516/
The expression of cannabinoid receptor 1 is significantly increased in atopic patients (full–2014) http://www.jacionline.org/article/S0091-6749%2813%2902936-9/fulltext
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis (full–2014) http://www.biomedcentral.com/1471-2474/15/275
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984273/
Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion (full–2014) http://www.biomedcentral.com/2050-6511/15/30
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1 (full–2014) http://www.jleukbio.org/content/95/4/609.long
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089388/
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997281/
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036321/
top
Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081916/
What we know and do not know about the cannabinoid receptor 2 (CB2) (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567276/
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261058/
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170074/
Inhaled medicinal cannabis and the immunocompromised patient (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25216851
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
CANNABINOIDS INCREASE LUNG CANCER CELL LYSIS BY LYMPHOKINE-ACTIVATED KILLER CELLS VIA UPREGULATION OF ICAM-1 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25069049
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25245379
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full–2015) http://www.hindawi.com/journals/mi/2015/349176/
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function (full–2015) http://link.springer.com/article/10.1007/s11481-015-9615-z/fulltext.html
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
Endocannabinoid signaling in innate and adaptive immunity (abst–2015) http://onlinelibrary.wiley.com/doi/10.1111/imm.12441/abstract
Endocannabinoid signaling in innate and adaptive immunity (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/imm.12441/full
Pathogenesis of Systemic Sclerosis (full–2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA (full–2015) http://www.nature.com/srep/2015/150505/srep09887/full/srep09887.html
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system,
and arthritis (full–2015) http://www.arthritis-research.com/content/17/1/226
Expression Analysis of CB2-GFP BAC Transgenic Mice (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138986
Cannabis – the Israeli perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0091/jbcpp-2015-0091.xml
Restoring homeostasis of CD4(+) T cells in hepatitis-B-virus-related liver fibrosis (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i38/10721.htm
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression? (full–2015) http://link.springer.com/article/10.1007/s00213-015-4105-9/fulltext.html
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice (full-2015) http://www.ncbi.nlm.nih.gov/pubmed/26584135
top
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis (full–2015) http://link.springer.com/article/10.1186/s13075-015-0743-x
Δ9 Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived cell activation via STAT3/S100A8 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25713087
Effects of Cannabinoids on T-cell Function and Resistance to Infection (full–2015) http://tinyurl.com/oqjfy9j
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites (full–2015) http://www.jleukbio.org/content/97/6/1049.long
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo (full–2015) http://www.jimmunol.org/content/194/11/5211.long
A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10 (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528965/
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504841/ Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541500/
Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation (link to PDF-2015) http://www.mdpi.com/1422-0067/16/4/7057
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25586586
The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts (abst-2015) http://www.sciencedirect.com/science/article/pii/S0024320515001290
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461500055X
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25791728
Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25900076
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935384
Downstream effects of endocannabinoid on blood cells: implications for health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957591
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26303348
Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25545473
Endocannabinoids and the Immune System in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408161
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
Combined effects of HIV and marijuana use on neurocognitive functioning and immune status (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26694807
Dietary Carbohydrates that Modulate the Immune System (abst–2015) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=60
Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model (abst–2015) http://link.springer.com/article/10.1007/s11481-015-9599-8
Lipid signaling in adipose tissue: Connecting inflammation & metabolism (abst–2015) http://www.sciencedirect.com/science/article/pii/S1388198114002091
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13337/full
top
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2 (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=7042&path%5B%5D=20008
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm
A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0152913
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0603-x
Acetaminophen Attenuates House Dust Mite Induced Allergic Airway Disease in Mice (full–2016) http://jpet.aspetjournals.org/content/early/2016/07/08/jpet.116.233684.long
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation. (full–2016) https://www.hindawi.com/journals/mi/2016/5831315/ CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
The CB2 receptor and its role as a regulator of inflammation (full–2016) http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
Longitudinal examination of the intestinal lamina propria cellular compartment of SIVinfected rhesus macaques provides broader and deeper insights into the link between aberrant microRNA expression and persistent immune activation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859716/
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens (full–2016) http://www.tandfonline.com/doi/full/10.4081/ijas.2015.3473
Synthetic Cannabinoid-Induced Immunosuppression Augments Cerebellar Dysfunction in Tetanus-Toxin Treated Mice (link to PDF–2016) http://www.biomolther.org/journal/view.html?uid=731&vmd=Full
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation. (click “Molecular Medicine” for PDF– 2016) http://www.ncbi.nlm.nih.gov/pubmed/26772776
Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse – the probable role of molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent – case report (link to download – 2016) http://www.mppt.hu/folyoirat/1/abstract/? vol=18&issue=3&elsooldal=162 3D
Structure of Protein That Guides the Immune System Uncovered (news & abst–2016) http://neurosciencenews.com/trpv2-ion-channel-immune-system-3448/
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions. (abst – 2016) http://www.eurekaselect.com/138448/article
Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27038180
Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed type hypersensitivity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27064137
No significant effect of cannabis use on the count and percentage of circulating CD4 Tcells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27073179
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301459
Chronic Δ9-Tetrahydrocannabinol Administration Reduces IgE+B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27109234
Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production (abst–2016) http://www.jrijournal.org/article/S0165-0378%2816%2930026-2/abstract
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27237820
Ethanol downregulates N-acyl phosphatidylethanolamine-phospholipase D expression in BV2 microglial cells via epigenetic mechanisms (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27266665
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27287619
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27327245 Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
Microglia activation states and cannabinoid system: Therapeutic implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373505
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26999797
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816309021
Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27694494
Effect of marijuana use on thyroid function and autoimmunity (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27799014
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation (abst–2016) http://www.sciencedirect.com/science/article/pii/S0008874916301356
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27992060
Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system? (abst–2016) http://link.springer.com/article/10.1007%2Fs00441-016-2544-1
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28011441
Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28041663
Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo (abst–2017) http://pubs.rsc.org/en/Content/ArticleLanding/2017/PP/C6PP00337K#!divAbstract


IMMUNE THROMBOCYTOPENIA
Immune thrombocytopenia in children and adults: what’s the same, what’s different? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232253/
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
Childhood immune thrombocytopenia-who will spontaneously recover? (full–2013) http://www.seminhematol.org/article/S0037-1963%2813%2900032-2/fulltext
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23406660
2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614031/
Synthetic marijuana “K2” induced ITP (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24749892
Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301277
top


INDICATIONS AND CLINICAL USES
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada) (full–2010) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
“Who Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinics” (abst+news–2010) http://blog.norml.org/2011/07/21/who-are-americas-medical-marijuana-patients/
Cannabis and Its Derivatives: Review of Medical Use (full–2011) http://www.jabfm.org/cgi/content/full/24/4/452
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673028/
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Medical Marijuana: Clearing Away the Smoke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
Therapeutic Potentials and uses of Cannabinoid Agonists in Health and Disease Conditions (full–2012) http://maxwellsci.com/print/bjpt/v3-76-88.pdf
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Marijuana: modern medical chimaera (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22873011
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23103355
Cannabis Strain Explorer (web page–2012) http://www.leafly.com/explore
Therapeutic potential of cannabinoid medicines (full-2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
The pharmacologic and clinical effects of medical cannabis (full-2013) http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/full
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24095000
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23588562
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Medical marijuana: more questions than answers (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25226202
Medical marijuana: more questions than answers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243838/
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases (report–2014) http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement
Report on Medical Cannabis Research, What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst–2014) http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
top
Plant derived substances with anti-cancer activity: from folklore to practice (full-2015) http://journal.frontiersin.org/article/10.3389/fpls.2015.00799/full
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25650954
Medicinal cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674028/ Evidence for Medicinal Use of Cannabis (article–2016) http://www.physio-pedia.com/Evidence_for_Medicinal_Use_of_Cannabis Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883


INFANTS
Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child (full–2010) http://www.cannabis-med.org/data/pdf/en_2010_04_1.pdf
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?tool=pubmed
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia (full–2010) http://stroke.ahajournals.org/content/41/12/2956.long
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
Examining the Health and Drug Exposures among Canadian Children Residing in Drug-Producing Homes (full–2010) http://www.jpeds.com/article/S0022-3476%2811%2900522-1/abstract
Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine (full–2010) http://www.unboundmedicine.com/medline/ebm/record/20634020/abstract/Prolonged_coma_in_a_child_due_to_hashish_ingestion_with_quantitation_of_THC_metabolites_in_urine_
Unresolved Discrepancies between Cannabinoid Test Results for Infant Urine (full–2012) http://www.clinchem.org/content/58/9/1364.full
Acute cannabis poisoning in a 10-month-old infant (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22652516
Cannabinoid modulation of mother-infant interaction: is it just about milk? (abst–2012) http://www.degruyter.com/abstract/j/revneuro.2012.23.issue-5-6/revneuro-2012-0074/revneuro-2012-0074.xml?rskey=wRYgJd&result=1&q=cannabinoid
Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay. (abst–2012) http://www.sciencedirect.com/science/article/pii/S0009912012001518
The role of child protection in cannabis grow-operations (full–2013) http://www.canorml.org/ child.welfare.pdf
The consequences of pain in early life: injury-induced plasticity in developing pain pathways (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264936/
Meconium Drug Testing in Multiple Births in the USA (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24927721
Contribution of in utero drug exposure when interpreting hair results in young children (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25450508
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/early/2015/06/10/archdischild-2014-306284.long
A cannabinoid-intoxicated child treated with dexmedetomidine: a case report (full–2015) http://www.jmedicalcasereports.com/content/9/1/152
Unintentional Pediatric Exposure to a Synthetic Cannabinoid (AB-PINACA) Resulting in Coma and Intubation (full–2015) http://www.annemergmed.com/article/S0196-0644%2815%2900426-6/fulltext
Lipid mediator profile in vernix caseosa reflects skin barrier development (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629127/
top
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide / endocannabinoid signaling system associated to memory impairments in postweaned rats (full–2015) http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
Prenatal exposure to recreational drugs affects global motion perception in preschool children (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652269/
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25960036
Association between paracetamol use in infancy or childhood with body mass index (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25864407
Use of paracetamol during pregnancy and child neurological development (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25851072
Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26347521
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial (abst–2015) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2815%2900379-8/abstract
Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25882081
Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25915139
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25963415
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Maternal marijuana use and neonatal morbidity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26026918
Pharmacological Preventions of Brain Injury Following Experimental Germinal Matrix Hemorrhage: an Up-to-Date Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26561051
Association between marijuana use and adverse obstetrical and neonatal outcomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26401751
Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25895138
Sudden onset unexplained encephalopathy in infants: think of cannabis intoxication (abst-2015) http://link.springer.com/article/10.1007/s00431-015-2639-9
Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling (full–2016) http://www.nature.com/articles/srep21931
Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications (full–2016) http://www.sciencedirect.com/science/article/pii/S0890623816300715
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044872/
Detecting biomarkers of secondhand marijuana smoke in young children (link to PDF– 2016) http://www.nature.com/pr/journal/vaop/naam/abs/pr2016261a.html
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26946127
Marijuana Use and Its Effects in Pregnancy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27263998
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27634313
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686886
Cannabinoid Receptor 2 Activation Restricts Fibrosis and Alleviates Hydrocephalus after Intraventricular Hemorrhage (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27769788
Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center (abst–2016) http://www.sciencedirect.com/science/article/pii/S0009912016306087
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27959272


INFLAMMATION
Cannabinoid-induced apoptosis in immune cells as a pathway to immuno-suppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Cannabinoids and Viral Infections (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903762/?tool=pmcentrez
The endocannabinoid system as a target for the treatment of neurodegenerative disease (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931550/?tool=pubmed
top
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?tool=pubmed
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation (full-2010) http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2010214a.html
Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and Anti-Inflammatory Agents (full–2010) http://etd.uthsc.edu/WORLD-ACCESS/Gurley/2010-030-Gurley.pdf
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197781/
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full–2010) http://www.biomedcentral.com/1471-2202/11/44
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/?tool=pubmed
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice (full–2010) http://jpet.aspetjournals.org/content/334/3/973.long
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases (full–2010) http://www.freepatentsonline.com/EP2044935A1.html
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20868672
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/21056512/abstract/Beneficial_effects_of_cannabinoids__CB__in_a_murine_model_of_allergen_induced_airway_inflammation:_Role_of_CB_1_/CB_2__receptors_
Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19931394
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full–2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Gut feelings about the endocannabinoid system (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01689.x/full
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?tool=pubmed
Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents (full–2011) http://www.molecularpain.com/content/pdf/1744-8069-7-31.pdf
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
top
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423254/
The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198780/?tool=pubmed
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full–2011) http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/pdf/bph0163-1479.pdf
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ(9)-tetrahydrocannabinol in BV-2 microglial cells (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01461.x/pdf
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/pdf/nihms278422.pdf
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132458/pdf/cr201160a.pdf
Resolution of inflammation by N-arachidonoylglycine (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196844/
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01444.x/full
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206470/
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents (full–2011) https://www.google.com/patents/US7884133?dq=patent+7884133&hl=en&sa=X&ei=Ujb0U_6EEIW5ogSl84LYDg&ved=0CB4Q6AEwAA Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF–2011) http://www.tswj.com/2011/230786/abs/
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation (full–2011) http://www.fasebj.org/content/25/8/2711.long
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21850403
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21492165/abstract/A_synthetic_cannabinoid_CP55940_inhibits_lipopolysaccharide_induced_cytokine_mRNA_expression_in_a_cannabinoid_receptor_independent_mechanism_in_rat_cerebellar_granule_cells_
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21310228
top
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21601562
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation (abst-2011) http://www.abstractsonline.com/plan/ViewAbstract.aspx?sKey=94b35de1-74b2-4d46-b062-7c104b5df681&cKey=eca34a2d-da44-4938-b0fa-3a6e652a1756
Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers betaamyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292807/
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer’s Disease (full–2012) http://download.cell.com/cell-reports/mmcs/journals/2211-1247/PIIS2211124712001258.mmc2.pdf
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full–2012) http://www.jneuroinflammation.com/content/9/1/79
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Non-inflammatory Pain (full–2012) http://jpet.aspetjournals.org/content/338/1/114.full
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408184/
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuro-inflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
N-acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids – From fishy endocannabinoids to potential leads (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/bph.12030/full
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full–2012) http://www.jneuroinflammation.com/content/9/1/10
Update on the role of cannabinoid receptors after ischemic stroke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?tool=pubmed
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388241/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?tool=pubmed
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full–2012) http://www.jneuroinflammation.com/content/9/1/79
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/
Cannabinoid modulation of neuroinflammatory disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0050968
top
Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483099/
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice and induces weight gain and inflammation in mice (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548985/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01889.x/pdf
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423256/
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912000052
Differential Modulation by Delta(9)-Tetrahydrocannabinol (∆ (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657729/
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full–2012) http://www.jneuroinflammation.com/content/9/1/135
Activation of Cannabinoid Receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms (full–2012) http://ajpgi.physiology.org/content/304/2/G181
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632657/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells (full–2012) http://www.spandidospublications.com/or/28/4/1176;jsessionid=52ED17697BFDC92E6F5F848306023474?text=fulltext
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325902/
Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488886/
DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513945/
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912008485
top
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3312.long
Endocannabinoids limit excessive mast cell maturation and activation in human skin (full–2012) http://www.jacionline.org/article/S0091-6749%2811%2901796-9/fulltext
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476512/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/ Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging (full – 2012) http://file.scirp.org/Html/1-8201656_23229.htm
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice (full–2012) http://www.jleukbio.org/content/91/6/911.full
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer’s disease via regulation of β-secretase activity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22330831?dopt=Abstract&holding=f1000,f1000m,isrctn
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22367605
Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22269477
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22634229
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis (abst–2012) http://www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/116.7?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22178458
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22777139
Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22772472
Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22807196
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22877651
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22903455
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22971837
N-arachidonoyl glycine induces macrophage apoptosis via GPR18 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22266325
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst–2012) http://content.karger.com/produktedb/produkte.asp?doi=339113
top
Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337336
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/glia.22366/abstract
Neuroprotective agents: cannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21420365
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23253273
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337285
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001980
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full–2013) http://www.jneuroinflammation.com/content/10/1/20
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immuno-suppressive properties (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080022
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663904/
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717616/
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2013) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067427
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice (full–2013) http://arthritis-research.com/content/15/6/R192
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full–2013) http://www.jneuroinflammation.com/content/10/1/91
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6 (full–2013) http://www.pnas.org/content/110/43/17558.long
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier (full-2013) http://ajp.amjpathol.org/article/S0002-9440%2813%2900557-9/fulltext
Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650391/
top
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation (full–2013) http://www.jimmunol.org/content/190/10/4929.long
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full–2013) http://www.sciencedirect.com/science/article/pii/S0969996113001939
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis (full-2013) http://www.nature.com/labinvest/journal/v93/n3/full/labinvest2012177a.html
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641032/
Prospects for cannabinoid therapies in viral encephalitis (full–2013) http://www.sciencedirect.com/science/article/pii/S0006899313011694
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752375/
Anti-inflammatory effects of Cannabinoid 2 Receptor activation in endotoxin-induced uveitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954484/
Cannabinoid receptor modulation of the endothelial cell inflammatory response (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791499/ Cytokine release in sepsis (full–2013) http://file.scirp.org/Html/36257.html Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying CannabinoidMediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634783/
Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice (link to PDF-2013) http://www.eurekaselect.com/107975/article
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoyl-ethanolamide in Models of Alzheimer’s Disease (link to PDF-2013) http://www.eurekaselect.com/107977/article
New Insights in Mast Cell Modulation by Palmitoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107979/article
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23382309
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454360
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23518609
Endocannabinoids: A unique opportunity to develop multitarget analgesics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23623250
Endocannabinoids: A unique opportunity to develop multitarget analgesics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23623250
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation (abst–2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/120.12?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide:
A Case Report (abst–2013) http://www.eurekaselect.com/105507/article
top
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23849204
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electro-acupuncture on experimental arthritis of the rat temporomandibular joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23892791
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23891880
Cannabidiol in inflammatory bowel diseases: a brief overview (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22815234
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23901038
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22850623
Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells : magnolol inhibits LPS-induced inflammatory response (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23515857
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24275607
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuro-inflammation and apoptosis after neonatal ischemic brain damage (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23376684
Endocannabinoids: a unique opportunity to develop multitarget analgesics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23623250
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24384256
New insights in mast cell modulation by palmitoylethanolamide (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23394523
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22697514
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full–2014) http://www.jbc.org/content/early/2014/03/18/jbc.M113.536953.long
Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974854/
Inhibition of Fatty Acid binding proteins elevates brain anandamide levels and produces analgesia (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976407/
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases (full–2014) http://www.jpp.krakow.pl/journal/archive/04_14/pdf/183_04_14_article.pdf
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium (full–2014) http://ajpgi.physiology.org/content/307/2/G140
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat (full–2014) http://www.hindawi.com/journals/bmri/2014/971750/
top
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (full–2014) http://www.jci.org/articles/view/64628
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083038/
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis (full–2014) http://www.biomedcentral.com/1471-2474/15/275
Endocannabinoids and inflammatory response in periodontal ligament cells (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0107407
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0113161
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (full–2014) http://www.mdpi.com/1422-0067/15/8/13637/htm
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014376a.html
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201700/
Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular inflammatory responses to traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248435/
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12907/full
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183544/
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089388/
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain full–2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23461/full
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997281/
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques (full–2014) http://jvi.asm.org/content/89/2/1168.long
The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2014)
http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats (full–2014) http://ijnp.oxfordjournals.org/content/18/6/pyu111
top
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067767/
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon Npalmitoyl-ethanolamine levels and counteracts murine colitis (full–2014) http://www.fasebj.org/content/29/2/650.long
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (full–2014) http://ajpheart.physiology.org/content/307/11/H1655
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261058/
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206939/
Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain (full–2014) http://jpet.aspetjournals.org/content/351/1/224.long
Enhanced microglial activity in FAAH-/- animals (full–2014) http://www.sciencedirect.com/science/article/pii/S0024320514009795
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297696/
In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines (full–2014) http://file.scirp.org/Html/5-2500510_47691.htm
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844071/
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (link to PDF–2014) http://www.degruyter.com/view/j/cmble.2014.19.issue-3/s11658-014-0200-x/s11658-014-0200-x.xml
The endocannabinoid system: an emerging key player in inflammation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24419242
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24418364
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24529123
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25079058
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24561047
Host Neuro- Immuno-Endocrine Responses In Periodontal Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24588827
Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24588819
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24750433
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against
Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
top
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of
pressure overload (abst–2014) http://www.freedomwares.ca/p80cannabinoid-receptor-cb2-prevents-development-heart-failure-murinemodel-pressure-overload/
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23452/abstract
Increased oxidative stress enhances endocannabinoid tone (abst–2014) http://www.fasebj.org/content/28/1_Supplement/671.13.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25245379
Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25273317
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25344934
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25413674
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25463999
Neuroinflammation as a possible link between cannabinoids and addiction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25455257
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism? (abst–2014) http://www.eurekaselect.com/126560/article
Potential applications of marijuana and cannabinoids in medicine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators (abst–2014) http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147%2814%2900035-2
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24440533
Protective role of the cannabinoid receptor system in A2E-mediated photo-toxicity to retinal pigment epithelium (RPE) cells in an in-vitro model of age-related macular degeneration (AMD) (abst–2014) http://iovs.arvojournals.org/article.aspx?articleid=2271845&resultClick=1
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010 (abst–2014) http://www.drugandalcoholdependence.com/article/S0376-8716%2814%2901929-2/abstract?cc=y
NONRETROGRADE ENDOCANNABINOID SIGNALING MODULATES RETINAL GANGLION CELL CALCIUM HOMEOSTASIS THROUGH THE TRPV1 CATION CHANNEL (abst-2014)
http://iovs.arvojournals.org/article.aspx?articleid=2268407&resultClick=1
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation (abst–2014) http://gut.bmj.com/content/63/8/1300.abstract?sid=a8fb2a13-4493-4045-8855-9a0bae1e5d51
How Smoking Marijuana Might Be The Best Way To Prevent Alzheimer’s Disease (interview–2014) http://www.leafscience.com/2014/01/30/smoking-marijuana-might-best-way-prevent-alzheimers-disease/
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells (full–2015) http://www.hindawi.com/journals/mi/2015/362126/
top
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (full–2015) http://www.cps.org.tw/files/201503160252300.pdf
Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells (full–2015) http://www.jneuroinflammation.com/content/12/1/81
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function (full–2015) http://link.springer.com/article/10.1007/s11481-015-9615-z/fulltext.html
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/early/2015/06/10/archdischild-2014-306284.long
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129618
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures (full–2015) http://www.hindawi.com/journals/np/2015/130639/
CB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466920/
Time-Dependent Protection of CB2 Receptor Agonist in Stroke (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132487
Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA (full–2015) http://www.nature.com/srep/2015/150505/srep09887/full/srep09887.html
top
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/09/04/ijnp.pyv095.long
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis (full–2015) http://www.arthritis-research.com/content/17/1/226
Expression Analysis of CB2-GFP BAC Transgenic Mice (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138986
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567222/
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression? (full–2015) http://link.springer.com/article/10.1007/s00213-015-4105-9/fulltext.html
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/26584135
GPR55 – a putative “type 3” cannabinoid receptor in inflammation (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0080/jbcpp-2015-0080.xml
Oxyradical Stress, Endocannabinoids, and Atherosclerosis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686160/
Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human
Monocyte-Derived Dendritic Cells (MDDC) (full–2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.01452/full
Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26196692
Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner (full–2015) http://www.arthritis-research.com/content/17/1/321
Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-Induced Neuro-inflammation (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705409/
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26114153
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476410/
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26219414
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression,
epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722239/
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol,
decrease the activation of encephalitogenic T cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12637/full
Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acid. (full – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26500455 4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation. (full – 2015) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0307-7
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25425209
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium (full–2015)http://tinyurl.com/pv5snej
Effects of Cannabinoids on T-cell Function and Resistance to Infection (full–2015) http://tinyurl.com/oqjfy9j
Effects of Cannabinoids on T-cell Function and Resistance to Infection (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470840/
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites (full–2015) http://www.jleukbio.org/content/97/6/1049.long
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol (full–2015) http://file.scirp.org/Html/5-2500582_53912.htm
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26209559
Fatty acid amide hydrolase inhibitors: a patent review (2009-2014) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26413912
Fatty acid amide hydrolase inhibitors: a patent review (2009- 2014) (full–2015) http://www.tandfonline.com/doi/full/10.1517/13543776.2015.1067683
Polyunsaturated fatty acids and inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26397837
Polyunsaturated fatty acids and inflammation (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/iub.1428/full
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25869205
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12563/full
Distribution of Bioactive Lipid Mediators in Human Skin (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25668241
Distribution of Bioactive Lipid Mediators in Human Skin. (link to full through Elsevier–2015) http://www.ncbi.nlm.nih.gov/pubmed/25668241
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (click Full Text Links for PDF–2015) http://www.ncbi.nlm.nih.gov/pubmed/25687494
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation (link to PDF–2015) http://www.haematologica.org/content/early/2015/12/21/haematol.2015.136523.long
top
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25537576
Activation of cannabinoid receptor 2 attenuates synovitis and joint destruction in collagen-induced arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601571
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25173887
Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25637536
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25703248
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461500055X
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25791728
Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25833102
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25895887
The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25912803
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935384
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
top
Downstream effects of endocannabinoid on blood cells: implications for health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957591
Lipopolysaccharide-induced murine embryonic resorption involves changes in endocannabinoid profiling and alters progesterone secretion and inflammatory response by a CB1-mediated fashion (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958042
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058582
Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26189763
Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26095080
Impact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26194647
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists As Potential Treatment for Inflammatory Kidney Diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26228928
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26303348
Fatty acids, endocannabinoids and inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325095
Endocannabinoid regulation of amyloid-induced neuroinflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26362942
Lipopolysaccharide Suppresses Carboxylesterase 2g Activity and 2-Arachidonylglycerol Hydrolysis: A Possible Mechanism to Regulate Inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26403860
Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26410875
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
Deletion of G-protein coupled receptor 55 promotes obesity by reducing physical activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26447738
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26463937
A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26486424
top
Δ9-Tetrahydrocannabinol (Δ9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26607731
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants (abst–2015) http://www.eurekaselect.com/132200/article
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis (abst–2015) http://www.sciencedirect.com/science/article/pii/S1090023315004712
Endocannabinoids – at the crossroads between the gut microbiota and host metabolism (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26678807
Cell type-specific modulation of lipid mediator’s formation in murine adipose tissue by omega-3 fatty acids (abst–2015) http://www.sciencedirect.com/science/article/pii/S0006291X15310603
Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer’s disease mouse model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25443294
Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults (abst–2015) http://link.springer.com/article/10.1007/s10865-015-9625-6
Lipid signaling in adipose tissue: Connecting inflammation & metabolism (abst – 2015) http://www.sciencedirect.com/science/article/pii/S1388198114002091
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13337/full
Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoEDeficient Mice (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0146267
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0021915015301933
Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0484-z
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2 (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=7042&path%5B%5D=20008
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model (full–2016) http://anndermatol.org/DOIx.php?id=10.5021/ad.2016.28.1.22
Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome (full–2016) http://www.jlr.org/content/early/2016/02/17/jlr.M066308.long

Differential Regulation of Eicosanoid and Endocannabinoid Production by Inflammatory Mediators in Human Choriodecidua (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148306
Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7950&path[]=23319
New insights into the yin and yang of the endocannabinoid system in health and disease (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13451/full
CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury (full–2016) http://www.sciencedirect.com/science/article/pii/S0014488616300619
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing Remitting Multiple Sclerosis (full–2016) http://link.springer.com/article/10.1007/s13311-016-0420-z/fulltext.html
Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs? (full–2016) http://www.jleukbio.org/content/99/4/518.full
Protective Action of Anandamide and its COX-2 Metabolite against L-Homocysteine induced NLRP3 Inflammasome Activation and Injury in Podocytes (full–2016) http://jpet.aspetjournals.org/content/early/2016/05/10/jpet.116.233239.long
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0603-x
Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids (full–2016) http://www.sciencedirect.com/science/article/pii/S1995764516300712
CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids (full–2016) http://www.nature.com/articles/npjamd201612
Expression of the endocannabinoid receptors in human fascial tissue (full–2016) http://www.ejh.it/index.php/ejh/article/view/2643/2590
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921859/
The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858820/
Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812478/
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism (full–2016) http://www.jbc.org/content/early/2016/07/29/jbc.M116.746594.long Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161954
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation. (full–2016) https://www.hindawi.com/journals/mi/2016/5831315/
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00304/full
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040794/
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00343/full
The CB2 receptor and its role as a regulator of inflammation (full–2016) http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK (full–2016) http://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035052/
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
Longitudinal examination of the intestinal lamina propria cellular compartment of SIVinfected rhesus macaques provides broader and deeper insights into the link between aberrant microRNA expression and persistent immune activation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859716/
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse (full-2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047908/
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017608/
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation (full–2016) https://www.hindawi.com/journals/mi/2016/5831315/
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation (link to PDF-2016) http://press.endocrine.org/doi/10.1210/jc.2015-4381?url_ver=Z39.88-2003&rfr_id=ori%3Arid %3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation. (click “Molecular Medicine” for PDF– 2016) http://www.ncbi.nlm.nih.gov/pubmed/26772776
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis (link to full via ELSEVIER–2016) http://www.ncbi.nlm.nih.gov/pubmed/27133395
G protein-coupled receptor 18: A potential role for endocannabinoid signalling in metabolic dysfunction (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26337420
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst-2016) http://link.springer.com/chapter/10.1007/978-3-319-18497-5_24
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions (abst–2016) http://www.eurekaselect.com/138448/article
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S000927971530154X
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816000256
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26817719
Endocannabinoids in Cerebrovascular Regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825517
Anti-Inflammatory and Osteoprotective Effects of Cannabinoid-2 Receptor Agonist Hu- 308 in a Rat Model of Lipopolysaccharide-Induced Periodontitis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26846967
Cannabinoids for the Treatment of Schizophrenia: An Overview (abst–2016) http://www.eurekaselect.com/139245/article
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26896777 Role of cannabinoids in gastrointestinal mucosal defense and inflammation (abst–2016) http://www.eurekaselect.com/140045/article Endocannabinoid concentrations in hair are associated with PTSD symptom severity (abst–2016) http://www.psyneuen-journal.com/article/S0306-4530%2816%2930040-3/abstract
N-acyl ethanolamide and eicosanoid involvement in irritant dermatitis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26947140
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26993829
Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27038180
Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed type hypersensitivity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27064137
2-pentadecyl-2-oxazoline: identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816301037
Anandamide and its metabolites: what are their roles in the kidney? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27100705
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X1630076X
Mustard vesicants alter expression of the endocannabinoid system in mouse skin (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X16300898
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27129498
Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production (abst–2016) http://www.jrijournal.org/article/S0165-0378%2816%2930026-2/abstract
Cannabis for refractory psoriasis-high hopes for a novel treatment and a literature review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27164964
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27189876
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16301150
The effect of cannabinoids on dinitrofluorobenzene-induced experimental asthma in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27216000
Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental GMH rat model (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27261088
Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/27268717
N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNF- α-induced human umbilical vein endothelial cells by activating CB2 and PPAR-α (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27281236
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammationdriven rat models of Parkinson’s disease (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014488616301790
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27327245
Docosahexaenoic acid attenuates in endocannabinoid synthesis in RAW 264.7 macrophages activated with benzo(a)pyrene and lipopolysaccharide (abst–2016) http://www.sciencedirect.com/science/article/pii/S0378427416301667
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
LINOLEIC ACID AND THE PATHOGENESIS OF OBESITY (abst–2016) http://www.sciencedirect.com/science/article/pii/S1098882316300363
Microglia activation states and cannabinoid system: Therapeutic implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373505
The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration (abst–2016) http://link.springer.com/article/10.1007%2Fs00011-016-0969-3
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453335
Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450703
Cannabinoids, inflammation, and fibrosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27435265
Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27425766
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529509 The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561826
Endocannabinoids inhibit neurogenic inflammation in murine joints by a non-canonical cannabinoid receptor mechanism (abst–2016) http://www.neuropeptidesjournal.com/article/S0143-4179(16)30047-6/abstract
Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816303665
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623929
Δ9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell Permeability through CB2 Receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006295216302878
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27649266
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23–IL-17 signalling in macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302499
Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27694494
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27714895
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717112
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27720681
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and Nacylethanolamine acid amidase inhibitors (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00538
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27767974
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27784678 Cannabinoids, inflammation, and fibrosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27435265
Medical Marijuana: Just the Beginning of a Long, Strange Trip? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27660328
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27832442
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834685
The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27840942 Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524 CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27992060
The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis (abst–2016) http://link.springer.com/article/10.1007%2Fs10620-016-4404-y
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27997038
WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism (full–2017) https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0783-4
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (full–2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28100744
Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28103941
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107775
Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28110689 Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138
Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo (abst–2017) http://pubs.rsc.org/en/Content/ArticleLanding/2017/PP/C6PP00337K#!divAbstract
N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28065729
top


INTERACTIONS WITH OTHER DRUGS
THC Prevents MDMA Neurotoxicity in Mice (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824821/
Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813317/?tool=pubmed
Adolescent cannabis use increases risk for cocaine-induced paranoia (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821949/pdf/nihms156770.pdf
Opioid antagonism enhances marijuana’s effects in heavy marijuana smokers (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923559/pdf/nihms201310.pdf
Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/21116612
Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors (abst–2010)
http://www.ncbi.nlm.nih.gov/pubmed/20378129
Probable Interaction Between Warfarin and Marijuana Smoking (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/19531696/abstract/Probable_Interaction_Between_Warfarin_and_Marijuana_Smoking__July/August__
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative / Nitrosative Stress, Inflammation, and Cell Death (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682269/
The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645879/
Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol) (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033515/?tool=pmcentrez
Inhibition of monoacylglycerol lipase (MAGL) attenuates NSAID-induced gastric hemorrhages in mice (full–2011) http://jpet.aspetjournals.org/content/early/2011/06/09/jpet.110.175778.long
Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242894/pdf/nihms328208.pdf
Combined effects of THC and caffeine on working memory in rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423236/
Clozapine and SCH 23390 prevent the spatial working memory disruption induced by
Δ9-THC administration into the medial prefrontal cortex (full–2011) http://www.sciencedirect.com/science/article/pii/S0006899311001533
Cannabinoid system and cyclooxygenases inhibitors (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056416/?tool=pubmed
Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101004/pdf/zpt724.pdf
top
Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018238/
A combined preclinical therapy of cannabinoids and temozolomide against glioma (full–2011) http://mct.aacrjournals.org/content/10/1/90.full
Efavirenz interference in urine screening immunoassays for tetrahydrocannabinol (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22067092
Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity (abst-2011) http://ajh.sagepub.com/content/28/5/297
Possible involvement of the endocannabinoid system in memory modulation effect of general anesthetics (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21555187/abstract/Possible_involvement_of_the_endocannabinoid_system_in_memory_modulation_effect_of_general_anesthetics_
Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the betalactam antibiotic, ceftriaxone, in mice (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21536061/abstract/Role_of_GLT_1_transporter_activation_in_prevention_of_cannabinoid_tolerance_by_the_beta_lactam_antibiotic_ceftriaxone_in_mice_
Cannabinoid-opioid interaction in chronic pain (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/22048225/abstract/Cannabinoid_opioid_interaction_in_chronic_pain_
Cannabidiol potentiates Δ(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21667074
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21062637/abstract/The_interplay_of_cannabinoid_and_NMDA_glutamate_receptor_systems_in_humans:_preliminary_evidence_of_interactive_effects_of_cannabidiol_and_ketamine_in_healthy_human_subjects_
THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21716095/abstract/THC_methadone_and_THC_naltrexone_interactions_on_discrimination_antinociception_and_locomotion_in_rats_
Pharmacokinetics of a combination of Δ9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shock (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21341278/abstract/Pharmacokinetics_of_a_combination_of_%CE%949_tetrahydro_cannabinol_and_celecoxib_in_a_porcine_model_of_hemorrhagic_shock_
Low-volume binary drug therapy for the treatment of hypovolemia (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21330941/abstract/Low_volume_binary_drug_therapy_for_the_treatment_of_hypovolemia_
β-adrenergic Antagonists, Carbonic Anhydrase Inhibitors And α2-agonists Reduce The Effects Of Cannabinoids In A Rat Glaucoma Model (abst-2011) http://iovs.arvojournals.org/article.aspx?articleid=2360875&resultClick=1
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21243485
Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis (full–2012) http://www.if-pan.krakow.pl/pjp/pdf/2012/3_723.pdf
Changes of Blood Endocannabinoids during Anaesthesia: a Special Case for Fatty Acid Amide Hydrolase Inhibition by Propofol? (full–2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394128/
top
Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258357/
Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189263/
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959123/
Effects of ethanol, Δ(9)-tetrahydrocannabinol, or their combination on object recognition  memory and object preference in adolescent and adult male rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477605/
β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312970/
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydro-cannabinol and Cannabidiol in Rodent Models of Schizophrenia (link to PDF–2012) http://www.eurekaselect.com/102848/article
Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22426202
Effect of ACEA-a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22789660
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/syn.21586/abstract
Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22880540
Interactions between mu opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration (full–2013) http://jpet.aspetjournals.org/content/early/2013/03/27/jpet.113.204099.long
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in
multiple sclerosis-related spasticity: a case report (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625014/
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers (full–2013) http://www.springerplus.com/content/2/1/236
Dual Inhibition of Endocannabinoid Catabolic Enzymes Produces Enhanced Anti-Withdrawal Effects in Morphine-Dependent Mice (full–2013) http://www.ncbi.nlm.nih.gov/pubmed/23303065
Dissociation of the Pharmacological Effects of THC by mTOR Blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656376/
AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced
Cognitive Deficit (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586915/
Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12425/full
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/prp2.17/full
top
Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy (full-2013) http://jpet.aspetjournals.org/content/early/2013/06/25/jpet.113.206003.long
Prior Exposure to THC Increases the Addictive Effects of Nicotine in Rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656362/
Efavirenz does not cause false-positive urine cannabis test in HIV-infected patients on Highly Active Anti-Retroviral Therapy (full–2013) http://www.e-mjm.org/2013/v68n3/Efavirenz.pdf
Acute Δ9-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053165/
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2 (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/ijc.28591/full
Acute Psychosis Associated with Recreational Use of Benzofuran 6-(2-Aminopropyl)Benzofuran (6-APB) and Cannabis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770991/
Impact of Cannabis Use during Stabilization on Methadone Maintenance Treatment (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717827/
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review (full-2013) http://www.tandfonline.com/doi/full/10.3109/03602532.2013.849268
Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol? (full–2013) http://journals.sagepub.com/doi/full/10.1177/0269881112446534
Cannabis and Cigarettes (abst–2013) http://jama.jamanetwork.com/article.aspx?articleid=1681388&resultClick=3
Interactions between mu opioid receptor agonists and cannabinoid receptor agonists CP55940 and WIN55212-2 in rhesus monkeys: evaluation of treatment- and abuserelated effects (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.3?sid=7a3e6978-9a8c-4319-bca1-9f80fed2445f
Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23523958
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24157976
Activation of type-2 cannabinoid receptor inhibits neuroprotective and anti-inflammatory actions of glucocorticoid receptor α: when one is better than two (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296125
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22862835
Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB 2 receptor agonist)
on the protective action of various classical antiepileptic drugs in the mouse 6 Hz
psychomotor seizure model (full–2014) http://download.springer.com/static/pdf/828/art%253A10.1007%252Fs00702-014-1173-7.pdf?auth66=1393191519_d7b51017bd9f9b481c18158f0312786b&ext=.pdf
Cyclosporine and Herbal Supplement Interactions (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913293/
Updates on the Clinical Evidenced Herb-Warfarin Interactions (full–2014) http://www.hindawi.com/journals/ecam/2014/957362/
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity (full–2014) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098079&representation=PDF
Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934591/
top
Pregnenolone can protect the brain from cannabis intoxication (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057431/
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250392/
Impact of efficacy at the mu opioid receptor on antinociceptive effects of combinations of mu opioid receptor agonists and cannabinoid receptor agonists (full–2014) http://jpet.aspetjournals.org/content/early/2014/09/05/jpet.114.216648.long
Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2 /’Spice’ constituent JWH-018 in mice (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157458/
Acute administration of Δ9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945413/
Cannabis Withdrawal in Patients With and Without Opioid Dependence (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127106/
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced
dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24709540
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747871
Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute d-amphetamine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24867330
Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25010019
Effects of opioids and cannabinoids during chronic morphine treatment in rhesus monkeys (abst–2014) http://www.fasebj.org/content/28/1_Supplement/658.3.abstract?sid=467bb529-0ecc-4ddc-af27-3f56f520a102
Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25485642
Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25533893
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS (abst–2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868391#sthash.uxbwgudh.dpuf
RESOLUTION OF SEIZURES AND NORMALIZATION OF EEG AFTER INITIATION OF CBD IN A PATIENT WITH DOOSE SYNDROME (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868186#sthash.4suBa1in.dpuf
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol (full–2015) http://www.clinchem.org/content/61/6/850.long
top
Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499434/
Combined effects of marijuana and nicotine on memory performance and hippocampal volume (full–2015) http://www.sciencedirect.com/science/article/pii/S0166432815301005
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545660/
Combined effects of marijuana and nicotine on memory performance and hippocampal volume (full–2015) http://www.sciencedirect.com/science/article/pii/S0166432815301005
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2 (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580018/
13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25733759
Cigarette smoking may modify the association between cannabis use and adiposity in males (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26026899
Novel associations between FAAH genetic variants and postoperative central opioid related adverse effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25558980
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/epi.13060/full
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26187456
Cannabinoids and Epilepsy (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0375-5
The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26374993
The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats (link to download–2015) http://www.elis.sk/index.php? page=shop.product_details&flypage=flypage.tpl&product_id=4378&category_id=119&option=com_virtue mart&vmcchk=1&Itemid=1
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates (article–2015) http://journalofethics.ama-assn.org/2015/06/pfor2-1506.html
Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25592741
Anaesthetic consideration in a cannabis addict (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25933451
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25943166
Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179931
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26202613
Do Cannabinoid Receptor Agonists Have A Role In The Intensive Care Unit? … Totally Dude! (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A1657
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26257143
Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective Study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26260134
Clinical pharmacology of medical cannabinoids in chronic pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26267945
Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocananbinol in humans discriminating [INCREMENT]9-tetrahydrocananbinol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26313650
top
Genetic inactivation and prolonged pharmacologic inhibition of monoacylglycerol lipase have opposite effects on anesthetic sensitivity to propofol (abst–2015) http://www.sciencedirect.com/science/article/pii/S0014299915302247
Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26360322
Polypharmacology Shakes Hands with Complex Aetiopathology (abst–2015) http://tinyurl.com/hg6um8q
Khat (Catha edulis F) and cannabinoids: Parallel and contrasting behavioral effects in preclinical and clinical studies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26469212
Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26507196
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708108
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26720619
Influence of arachidonyl‐2′‐chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the anticonvulsant and acute side‐effect potentials of clobazam, lacosamide, and pregabalin in the maximal electroshock‐induced seizure model and chimney test in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25904357
Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26206340
Combined Treatment with Morphine and Δ9-Tetrahydrocannibinol (THC) in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal (abst–2015) http://www.fasebj.org/content/29/1_Supplement/616.9.abstract?sid=edf921ac-0690-4aa6-ac81-0546314dd384
Is cannabis use associated with less opioid use among people who inject drugs? (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900250-1/abstract
Nicotine Changes Marijuana’s Effect on the Brain (news & abstract-2015) http://neurosciencenews.com/hippocampal-volume-nicotine-marijuana-2457/ Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait (full–2016) http://www.hindawi.com/journals/np/2016/6481862/
A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder (full–2016) http://link.springer.com/article/10.1007/s11126-016-9426-2/fulltext.html
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl (full–2016) http://www.sciencedirect.com/science/article/pii/S0014299916303235
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10314&path%5B%5D=32486 Effect of interaction between acute administration of morphine and cannabinoid compounds on spontaneous excitatory and inhibitory postsynaptic currents of magnocellular neurons of supraoptic nucleus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951608/
High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana (full–2016) https://www.hindawi.com/journals/crit/2016/4028492/
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00343/full Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path%5B%5D=12721&path%5B%5D=40316
The selective monoacylglycerol lipase inhibitor MJN110 produces opioid sparing effects in a mouse neuropathic pain model (link to PDF–2016) http://jpet.aspetjournals.org/content/early/2016/01/20/jpet.115.229971.abstract?sid=97527854-e2fb-4d74- ad96-6ab0744dc240
Behavioral Characterization of Kappa Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats (link to download–2016) http://jpet.aspetjournals.org/content/early/2016/11/30/jpet.116.235630.long
Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive Behavior during Forced Abstinence from Alcohol Drinking (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26751284
The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders (abst–2016) http://link.springer.com/article/10.1007%2Fs00213-015-4188-3 CB1
Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens (abst–2016) http://link.springer.com/article/10.1007/s12031-016-0716-9
Combined treatment with morphine and Δ9-tetrahydrocannibinol (THC) in rhesus monkeys: antinociceptive tolerance and withdrawal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26937020
Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26970948
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26889611
Medical cannabis associated with decreased opiate medication use in retrospective crosssectional survey of chronic pain patients (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27001005
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27106177
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16301150
Opioid and cannabinoid synergy in a mouse neuropathic pain model. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27278681
Marijuana Use and Its Effects in Pregnancy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27263998
Substitution and Complementarity of Alcohol and Cannabis: A Review of the Literature (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27249324
Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27235655
Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27305347
Basolateral amygdala CB1 cannabinoid receptors are involved in cross state-dependent memory retrieval between morphine and ethanol (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716301083
Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27484692
Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450703
Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27502029
Marijuana and tobacco co-administration in blunts, spliffs, and mulled cigarettes: A systematic literature review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27654966
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl- 2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014299916306161
Interactive effects of AM251 and baclofen on synaptic plasticity in the rat dentate gyrus. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27663967
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl- 2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014299916306161
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305123
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306685
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites (abst–2016) http://link.springer.com/chapter/10.1007%2F7854_2016_60
Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28043732
top


INTRAVENTRICULAR HEMORRHAGE
Cannabinoid Receptor 2 Activation Restricts Fibrosis and Alleviates Hydrocephalus after Intraventricular Hemorrhage (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27769788


ISAACS’ SYNDROME/ACQUIRED NEUROMYOTONIA
Dramatic improvement of refractory Isaacs’ syndrome after treatment with dronabinol (full–2010) http://www.onlinepot.org/medical/IsaacsSyndrom.htm


IQ/MEMORY/COGNITIVE EFFECTS
Influence of cannabis use trajectories, grade repetition and family background on the school-dropout rate at the age of 17 years in France (full-2010) http://eurpub.oxfordjournals.org/content/20/2/157.long
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829220/?tool=pubmed
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906112/
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study (full-2010) http://bjp.rcpsych.org/content/197/4/285.long
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283159/
Evaluating the effect of aquatic extraction of Cannabis sativa seed on spatial memory consolidation (abst-2010) http://www.annals-general-psychiatry.com/content/9/S1/S143
Evaluating the effect of Cannabis sativa seed extraction on memory (abst-2010) http://www.annals-general-psychiatry.com/content/9/S1/S208
Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20004682
Gender moderates the impact of stereotype threat on cognitive function in cannabis users (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20483199
An Evidence Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions (full–2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037578/
AM251, cannabinoids receptors ligand, improves recognition memory in rats (full–2011) http://www.if-pan.krakow.pl/pjp/pdf/2011/3_670.pdf
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neuro-degeneration and therapeutic interventions (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Combined effects of THC and caffeine on working memory in rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423236/
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045517/
Sex, drugs, and cognition: effects of marijuana (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089380/?tool=pubmed
Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex (full–2011) http://www.sciencedirect.com/science/article/pii/S0006899311001533
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057300/
top
Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British Cohort Study (full–2011) (must register) http://www.academia.edu/1090026/Intelligence_across_childhood_in_relation_to_illegal_drug_use_in_adulthood_1970_British_Cohort_Study
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181427/pdf/fnbeh-05-00064.pdf
Effects of endocannabinoid system modulation on cognitive and emotional behavior (full–2011) http://journal.frontiersin.org/Journal/10.3389/fnbeh.2011.00057/full
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory (full–2011) http://www.nature.com/npp/index.html
Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156972/
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236282/
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
Propofol Enhances Memory Formation via an Interaction with the Endocannabinoid System (full–2011) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1933567
Fish oil promotes survival and protects against cognitive decline in severely under-nourished mice by normalizing satiety signals (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117120/
Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260974/
The dual neuroprotective-neurotoxic profile of cannabinoid drugs (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165949/
Patent WO 2010012506 A1 – CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA (full-2011) http://www.google.it/patents/WO2010012506A1?cl=en
Possible involvement of the endocannabinoid system in memory modulation effect of general anesthetics (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21555187/abstract/Possible_involvement_of_the_endocannabinoid_system_in_memory_modulation_effect_of_general_anesthetics_
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/20724033
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21798112
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21870037
4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20974250
Assessing topographical orientation skills in cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259701/?tool=pubmed
top
Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THClike Morris water maze deficits in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382457/
Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514639/
Extinction learning of rewards in the rat: is there a role for CB1 receptors? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161161/
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer’s disease (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154439/
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full–2012) http://www.jneuroinflammation.com/content/9/1/10
Intelligence quotient in childhood and the risk of illegal drug use in middle-age: the 1958 National Child Development Survey (full-2012) http://www.annalsofepidemiology.org/article/S1047-2797%2812%2900170-6/fulltext
The endocannabinoid system: a key modulator of emotions and cognition (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490098/
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3254.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Involvement of the endocannabinoid system in reward processing in the human brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266503/
Cannabis Responsive Head Injury Induced Mutiple Disabilities: A Case Report (full-2012) http://file.scirp.org/Html/9-2500130_16958.htm
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-β and in the cortex of aged rats (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464574/
Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ(9)-THC in Humans (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358754/
Adolescent Exposure of JWH-018 “Spice” Produces Subtle Effects on Learning and Memory Performance in Adulthood (full–2012) http://file.scirp.org/Html/2-3900080_19505.htm
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546149/
Cannabinoids and value-based decision making: implications for neurodegenerative disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496267/
Functional connectivity in brain networks underlying cognitive control in chronic cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376324/
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912008485
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD (full–2012) http://www.sciencedirect.com/science/article/pii/S0092867412001420
top
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuro-inflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
Effects of ethanol, Δ(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477605/
Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335956/
Adolescent Exposure of JWH-018 “Spice” Produces Subtle Effects on Learning and Memory Performance in Adulthood (full – 2012) http://file.scirp.org/Html/2-3900080_19505.htm
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23042808
Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22731735
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer’s disease via regulation of β-secretase activity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22330831?dopt=Abstract&holding=f1000,f1000m,isrctn
Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22173015
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22579951
Neurocognitive functioning and cannabis use in schizophrenia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716156
Pharmacological effects of cannabinoids on the reference and working memory functions in mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22903389
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)-tetrahydrocannabinol (THC): neuroprotection and ERK signaling (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22821081
Effects of Δ9-Tetrahydrocannabinol Administration on Human Encoding and Recall Memory Function: A Pharmacological fMRI Study (abst–2012) http://www.mitpressjournals.org/doi/abs/10.1162/jocn_a_00156?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&#.Va6zXvlwtB8
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0058926
Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors (full–2013) http://www.biomedcentral.com/content/pdf/1471-2202-14-20.pdf
Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0066387
Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12425/full
top
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
An investigation into “two hit” effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice (full–2013) http://www.frontiersin.org/Journal/10.3389/fnbeh.2013.00149/full
Effects of magnolol on impairment of learning and memory abilities induced by scopolamine in mice (full–2013) https://www.jstage.jst.go.jp/article/bpb/36/5/36_b12-00880/_html
Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600466/
A role for the endocannabinoid system in exercise-induced spatial memory enhancement in mice (full–2013) http://www.ncbi.nlm.nih.gov/pubmed/24115292
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662489/
COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682154/
AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586915/
Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682147/
Novelty-Induced Emotional Arousal Modulates Cannabinoid Effects on Recognition Memory and Adrenocortical Activity (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656371/
Dissociation of the Pharmacological Effects of THC by mTOR Blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656376/
Δ9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling (full–2013) http://www.cell.com/cell/abstract/S0092-8674%2813%2901360-3?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867413013603%3Fshowall%3Dtrue
Impact of ADHD and cannabis use on executive functioning in young adults (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820098/
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide
Hydrolase (FAAH) Genes, and Marijuana-Related Problems (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817049/
Cannabidiol attenuates deficits of visuo-spatial associative memory induced by Δ9-tetrahydrocannabinol (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838683/
Effects of a novel CB1 agonist on visual attention in male rats: Role of strategy and expectancy in task accuracy (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006576/
CB1 Receptor-Mediated Signaling Underlies the Hippocampal Synaptic, Learning and Memory Deficits Following Treatment with JWH-081, a New Component of Spice/K2 Preparations (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959795/
Differential effects of the cannabinoid agonist WIN55,212-2 on delay and trace eyeblink conditioning (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963426/
CB1 receptor signaling regulates social anxiety and memory (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12045/full
top
Performance in working memory and attentional control is associated with the rs2180619 SNP in the CNR1 gene (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12097/full The neuroprotective effects of cocoa flavanol and its influence on cognitive performance (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575938/
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22795792
Developmentally-induced hypothyroidism alters the expression of Egr-1 and Arc genes and the sensitivity to cannabinoid agonists in the hippocampus. Possible implications for memory and learning (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23079472
Effect of cannabinoid CB2 receptor agonism on learning and memory in a mouse model of photothrombosis (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.4?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.9?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23796670
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23838176
Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23906663
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24247477 Erratum to: Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats (correction to chart–2013) http://link.springer.com/article/10.1007%2Fs00213-013-3380-6
The endocannabinoid system: An emotional buffer in the modulation of memory function (abst–2013) http://www.sciencedirect.com/science/article/pii/S1074742713002669
The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895301/
Chronic ethanol alters network activity and endocannabinoid signaling in the prefrontal cortex (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnint.2014.00058/full
Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0114521
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders (full–2014) http://www.clinicalepigeneticsjournal.com/content/5/1/14
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates (full–2014) http://www.futuremedicine.com/doi/full/10.2217/pgs.14.151
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250392/
Neurocognition in college-aged daily marijuana users (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074777/
Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Up-regulation of MicroRNA-188-3p in a Mouse Model of Alzheimer’s Disease (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220026/
Impaired Fear Memory Specificity Associated with Deficient EndocannabinoidDependent Long-Term Plasticity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023141/
top
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area (full–2014) http://www.jneurosci.org/content/34/39/13096.long
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114400/
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor β/δ (PPARβ/δ) in the Brain (full–2014) http://www.jbc.org/content/289/18/12748.full.pdf+html
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses (full–2014) http://www.sciencedirect.com/science/article/pii/S0896627314000178
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398332/
Elevation of Endogenous Anandamide Impairs LTP, Learning and Memory through CB1 Receptor Signaling in Mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077345/
Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280626/
Amyrin Attenuates Scopolamine-Induced Cognitive Impairment in Mice (full–2014) https://www.jstage.jst.go.jp/article/bpb/37/7/37_b14-00113/_html
The Impact of a Motivational Statement and Age of Cannabis Use Onset on Neuro-psychological Test Performance (full–2014) https://www.researchgate.net/publication/268577210_The_impact_of_a_motivational_statement_and_age_of_cannabis_use_onset_on_neuropsychological_test_performance
Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis use Interact on Prefrontal Connectivity and Related Working Memory Behavior (full–2014) http://www.nature.com/npp/journal/v40/n3/full/npp2014213a.html
Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960373/
Endocannabinoid Signaling within the Basolateral Amygdala Integrates Multiple Stress Hormone Effects on Memory Consolidation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397407/
Multifractal analysis of information processing in hippocampal neural ensembles during working memory under Δ9-tetrahydrocannabinol administration (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312266/
Acute administration of THC impairs spatial but not associative memory function in zebrafish (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24639045
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23893294
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24853061
WIN55212-2 impairs non-associative, recognition and spatial memory in rats via CB1 receptor stimulation (abst–2014) http://www.sciencedirect.com/science/article/pii/S0091305714001555
CB1 receptor antagonism in the granular insular cortex or somatosensory area facilitates consolidation of object recognition memory (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/25004406
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (abst–2014) http://iospress.metapress.com/content/0617070q2404258h/?p=e36fa00480454cc9ae10e6351455c445&pi=4
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23452/abstract
top
Impact of Stress on Prefrontal Glutamatergic, Monoaminergic and Cannabinoid Systems (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25048388
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
Genetic variability in the human cannabinoid receptor 1 is associated with resting state EEG theta power in humans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25116250
Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25452006
Systemic or intra-amygdala infusion of an endocannabinoid CB1 receptor antagonist AM251 blocked propofol-induced anterograde amnesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25445359
CP55,940 attenuates spatial memory retrieval in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25443717
Activation of cannabinoid system in anterior cingulate cortex and orbitofrontal cortex modulates cost-benefit decision making (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25529106
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25024347
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24532152
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24589297
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full–2015)  http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189 (full–2015) http://www.mdpi.com/1422-0067/16/1/758/htm
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423390/
Effects of high-fructose diets on central appetite signaling and cognitive function (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429636/
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25560837
Task-specific enhancement of hippocampus-dependent learning in mice deficient in monoacylglycerol lipase, the major hydrolyzing enzyme of the endocannabinoid 2-arachidonoylglycerol (full–2015) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00134/full
top
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
Hormonal status and age differentially affect tolerance to the disruptive effects of delta-9-tetrahydrocannabinol (Δ(9)-THC) on learning in female rats (full–2015) http://journal.frontiersin.org/article/10.3389/fphar.2015.00133/full
Cannabis and psychopathology: The meandering journey of the last decade (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462782/
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Combined effects of marijuana and nicotine on memory performance and hippocampal volume (full–2015) http://www.sciencedirect.com/science/article/pii/S0166432815301005
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567222/
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, doubleblind, crossover pilot trial (full–2015) http://jop.sagepub.com/content/early/2015/11/12/0269881115615104.long
Perinatal asphyxia results in altered expression of the hippocampal acylethanol-amide/endocannabinoid signaling system associated to memory impairments in post-weaned rats (full–2015) http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669909/
Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00457/full
Biased Type 1 Cannabinoid Receptor Signalling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease (full–2015) http://molpharm.aspetjournals.org/content/early/2015/12/23/mol.115.101980.long
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441859/ Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373963/
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (full–2015) http://www.sciencedirect.com/science/article/pii/S0149763415001244
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26067584
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770330/
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats (full–2015) http://www.jneurosci.org/content/35/41/13962.long Mechanisms of stress in the brain (abst–2015) http://www.nature.com/neuro/journal/v18/n10/full/nn.4086.html
Mechanisms of stress in the brain (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933289/
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881115609073
Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675604/
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26032254
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552583/
Habenular CB1 Receptors Control the Expression of Aversive Memories (full–2015) http://www.cell.com/neuron/fulltext/S0896-6273(15)00729-1
The involvement of medial septum 5-HT1 and 5-HT2 receptors on ACPA-induced memory consolidation deficit: Possible role of TRPC3, TRPC6 and TRPV2 (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881115609021
The cannabinoid system in the retrosplenial cortex modulates fear memory consolidation, reconsolidation, and extinction (full  015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749733/
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Dissecting the cannabinergic control of behavior: The where matters (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/bies.201500046/abstract;jsessionid=222EC084D6C5E7ECF95BFF9D2752CFE4.f01t01
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25476564
Involvement of the serotonergic system of the ventral hippocampus (CA3) on amnesia induced by ACPA in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25771207
Effects of cannabinoid and glutamate receptor antagonists and their interactions on learning and memory in male rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25684318
Intraperirhinal cortex administration of the synthetic cannabinoid, HU210, disrupts object recognition memory in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25714419
The potential of inhibitors of endocannabinoid metabolism as anxiolytic and anti-depressive drugs-A practical view (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25791296
top
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25689415
The effects of chronic marijuana use on circadian entrainment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801606
The dual effect of CA1 NMDA receptor modulation on ACPA-induced amnesia in stepdown passive avoidance learning task (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25680309
The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843413
Cannabinoid functions in the amygdala contribute to conditioned fear memory in streptozotocin-induced diabetic mice: interaction with glutamatergic functions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25929688
Astroglial type-1 cannabinoid receptors (CB1): A new player in the tripartite synapse (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25967266
Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome (abst–2015 http://www.ncbi.nlm.nih.gov/pubmed/25979787
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058582
The influence of cannabinoids on learning and memory processes of the dorsal striatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26092091
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26099242
Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26238495
No additive effect of cannabis on cognition in schizophrenia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26235754
Fatty acid amide hydrolase inhibitor URB597 prevented tolerance and cognitive deficits
induced by chronic morphine administration in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26274041
top
Cannabinoids and Glucocorticoids in the Basolateral Amygdala Modulate HippocampalAccumbens Plasticity after Stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26289146
Blockade of GPR55 in the dorsolateral striatum impairs performance of rats in a T-maze paradigm (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26292188
Effect of nucleus accumbens shell 5-HT4 receptors on the impairment of ACPA-induced emotional memory consolidation in male Wistar rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26340366
Providing a food reward reduces inhibitory avoidance learning in zebrafish (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26342856
Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food Restricted Rats: Involvement of CB1 Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26354043
Anandamide mediates cognitive judgement bias in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26363193
GABAA receptors in the central amygdala are involved in memory retention deficits induced by cannabinoids in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26368844
Effect of combined doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague-Dawley) models of conditioned gaping (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26381155
N-Palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0009279715300697
The interactive role of CB1 and GABAB receptors in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26611204
Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis (abst–2015) http://www.psy-journal.com/article/S0165-1781%2815%2930166-9/abstract
Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26663094
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26681496
Involvement of the infralimbic cortex and CA1 hippocampal area in reconsolidation of a contextual fear memory through CB1 receptors: effects of CP55,940 (abst–2015) http://www.sciencedirect.com/science/article/pii/S1074742715002257
Synergistic effect between prelimbic 5-HT3 and CB1 receptors on memory consolidation deficit in adult male Sprague-Dawley rats: an isobologram analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26701293
Stress and memory: A selective review on recent developments in the understanding of stress hormone effects on memory and their clinical relevance (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708929
CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815303326
Combined effects of HIV and marijuana use on neurocognitive functioning and immune status (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26694807
Endocannabinoid signaling integrates multiple stress hormone effects on memory (abst–2015) http://www.psyneuen-journal.com/article/S0306-4530%2815%2900634-4/abstract
Effects of Synthetic Cannabinoid JWH-018 and Phytocannabinoid Δ9-THC on Learning and Memory in Mice (abst–2015) http://www.fasebj.org/content/29/1_Supplement/615.5.abstract?sid=edf921ac-0690-4aa6-ac81-0546314dd384
top
Ultra-low doses of tetrahydrocannabinol contribute to the survival of newly-born cells in the dentate gyrus of adult rats (abst–2015) http://link.springer.com/article/10.1134/S1819712415030046
Changes Marijuana’s Effect on the Brain (news & abstract-2015) http://neurosciencenews.com/hippocampal-volume-nicotine-marijuana-2457/
Cannabinoid Receptors May Control Aversive Memories (news & abstract-2015) http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study (full–2016) http://jop.sagepub.com/content/early/2016/01/06/0269881115622241.full
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands (full–2016) http://www.hindawi.com/journals/np/2016/9815092/
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory (full–2016) http://www.hindawi.com/journals/np/2016/9817089/
Comparisons of Δ9-tetrahydrocannabinol and Anandamide on a Battery of Cognition related Behavior in Nonhuman Primates (full–2016) http://jpet.aspetjournals.org/content/early/2016/01/29/jpet.115.228189.long
top
GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149034
NO2 inhalation promotes Alzheimer’s disease-like progression: cyclooxygenase-2- derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication (full–2016) http://www.nature.com/articles/srep22429
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157060 Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745 Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (full–2016) http://archinte.jamanetwork.com/article.aspx?articleid=2484906
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0160949
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00343/full
Marijuana – How Safe is it Really? (full–2016) https://journals.mcmaster.ca/iScientist/article/download/1104/991 Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males (full–2016) http://www.nature.com/tp/journal/v6/n11/full/tp2016225a.html
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747759/
Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719019/
Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model (full–2016) http://www.mdpi.com/2073-4425/7/9/56/htm
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00355/full
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review (full–2016) http://link.springer.com/article/10.1007%2Fs12035-016-0313-5
Paracetamol sharpens reflection and spatial memory: a double-blind randomized controlled study in healthy volunteers (full–2016) https://www.dovepress.com/paracetamol-sharpens-reflection-and-spatial-memory-a-double-blind-randpeer-reviewed-article-
DDDT Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1878929316300639
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00493/full
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system (click “Full Text Links” to download–2016) https://www.ncbi.nlm.nih.gov/pubmed/27903595
Synthetic Cannabinoid-Induced Immunosuppression Augments Cerebellar Dysfunction in Tetanus-Toxin Treated Mice (link to PDF–2016) http://www.biomolther.org/journal/view.html?uid=731&vmd=Full
Should we care about sativex-induced neurobehavioral effects? A 6-month follow-up study (link to PDF–2016) http://www.europeanreview.org/article/11188
Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats (link to PDF–2016) http://jpn.ca/articles-in-press/41-6-150363/
Ovariectomy Alters Gene Expression of the Hippocampal Formation in Middle-Aged Rats (link to PDF–2016) http://press.endocrine.org/doi/10.1210/en.2016-1516?url_ver=Z39.88-2003&rfr_id=ori%3Arid %3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults. (link via ELSEVIER to Full Text–2016) https://www.ncbi.nlm.nih.gov/pubmed/27889592
Harvesting Benefits from Cannabinoids (article–2016) http://www.cell.com/cell/fulltext/S0092-8674(16)31675-0
Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26739712
Impaired cued and spatial learning performance and altered cannabinoid CB1 receptor functionality in the substantia nigra in a rat model of diabetic neuropathy (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816300249
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26783729
Facilitatory effect of AM281 on recognition memory in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114015003254
Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26558620
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer’s Disease and Mild Cognitive Impairment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825096
Interplay between serotonin and cannabinoid function in the amygdala in fear conditioning (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820636
Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a CannabisBased Medicine (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26890764
Cannabinoid Control of Learning and Memory through HCN Channels (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273(16)00048-9?_returnURL=http%3A%2F %2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627316000489%3Fshowall%3Dtrue
The Hyperpolarization-Activated Cation Current Ih: The Missing Link Connecting Cannabinoids to Cognition (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273(16)00144-6?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627316001446%3Fshowall%3Dtrue
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26993829
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27033329
Keep off the grass? Cannabis, cognition and addiction (abst–2016) http://www.nature.com/nrn/journal/v17/n5/full/nrn.2016.28.html
Because difficulty is not the same for everyone: the impact of complexity in working memory is associated with cannabinoid 1 receptor genetic variation in young adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27108777
Comorbid Cannabis and Tobacco Use in Adolescents and Adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27175326
Neural mechanisms of sensitivity to peer information in young adult cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27068178
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27223629
Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816303187
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27261878
Activation of cannabinoid CB1 receptors in the ventral hippocampus improved stressinduced amnesia in rat (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27282634
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27317835
Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26833888
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH- 018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816302805
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304304
Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVDhemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S1074742716301307
The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings (abst–2016) http://www.sciencedirect.com/science/article/pii/S104366181630706X
Cannabinoid Receptor 1 (CNR1) Gene Variant Moderates Neural Index of Cognitive Disruption during Nicotine Withdrawal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453054
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816304375
Endocannabinoid signaling and memory dynamics: a synaptic perspective (abst–2016) http://www.sciencedirect.com/science/article/pii/S1074742716301319
Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27502029
Adolescent cannabis use: What is the evidence for functional brain alteration? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27514709
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27528659 Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883 Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816303550
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/27567873
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27582345
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27586843
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599483
Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey of Students at Four Universities in Germany (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27607062
Abnormal white matter integrity in synthetic cannabinoid users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27617779
Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection (abst–2016) http://www.sciencedirect.com/science/article/pii/S016643281630715X
The use of the Emotional – Object Recognition as an assay to assess learning and memory associated to an aversive stimulus in rodents (abst–2016) http://www.sciencedirect.com/science/article/pii/S0165027016302199
CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27737762
Cannabinoid Modulation of Memory Consolidation within the Cerebellum (abst–2016) http://www.sciencedirect.com/science/article/pii/S1074742716302969
A cannabinoid link between mitochondria and memory (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27828947
A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27810656 Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population? (abst–2016) http://www.sciencedirect.com/science/article/pii/S089142221630230X
Neuromodulatory effects of the dorsal hippocampal endocannabinoid system in dextromethorphan/morphine-induced amnesia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014299916307282
The effects of cannabis use on salience attribution: a systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27866486
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306685
Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28084855
URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28042028
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27964871
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA (full–2017) http://journals.sagepub.com/doi/abs/10.1177/0269881116684336?url_ver=Z39.88- 2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults (full–2017) http://www.sciencedirect.com/science/article/pii/S221315821630170X
(S)Pot on Mitochondria: Cannabinoids Disrupt Cellular Respiration to Limit Neuronal Activity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28076767
Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28112976
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28131675
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28138971